PMC:7195088 / 10278-10549 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"205","span":{"begin":245,"end":256},"obj":"Chemical"},{"id":"244","span":{"begin":172,"end":182},"obj":"Disease"}],"attributes":[{"id":"A205","pred":"tao:has_database_id","subj":"205","obj":"MESH:C502936"},{"id":"A244","pred":"tao:has_database_id","subj":"244","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"italized where RCT are not available or still to be implemented) and who are worsening while receiving standard supportive care (in the absence of concomitant/superimposed infections). In our opinion, this could be a reasonable off-label use of tocilizumab in these early"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T53","span":{"begin":172,"end":182},"obj":"Disease"}],"attributes":[{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"italized where RCT are not available or still to be implemented) and who are worsening while receiving standard supportive care (in the absence of concomitant/superimposed infections). In our opinion, this could be a reasonable off-label use of tocilizumab in these early"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T33","span":{"begin":215,"end":216},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T34","span":{"begin":232,"end":237},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"italized where RCT are not available or still to be implemented) and who are worsening while receiving standard supportive care (in the absence of concomitant/superimposed infections). In our opinion, this could be a reasonable off-label use of tocilizumab in these early"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T46","span":{"begin":232,"end":237},"obj":"Chemical"},{"id":"T47","span":{"begin":245,"end":256},"obj":"Chemical"}],"attributes":[{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":"italized where RCT are not available or still to be implemented) and who are worsening while receiving standard supportive care (in the absence of concomitant/superimposed infections). In our opinion, this could be a reasonable off-label use of tocilizumab in these early"}